(Q41952207)

14 October 2017

In vitro and in vivo antibacterial activity of AT-2266. (English)

1 reference

14 October 2017

Kouno K

1

1 reference

14 October 2017

Inoue M

series ordinal

2

1 reference

14 October 2017

Mitsuhashi S

series ordinal

3

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 July 1983

1 reference

Antimicrobial Agents and Chemotherapy

14 October 2017

1 reference

14 October 2017

24

1 reference

14 October 2017

78-84

1 reference

14 October 2017

1

1 reference

Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

In vitro antibacterial activity of norfloxacin (MK-0366).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185107

5 June 2018

Identifiers

DOI

10.1128/AAC.24.1.78

1 reference

14 October 2017

1 reference

14 October 2017

1 reference